5 Mayıs 20176 Mayıs 2017

5 Mayıs 2017,  1. Gün Cuma

13:00 – 13:10

Açılış
Dr. Sümer Baltacı

13:10 – 14:05

General session 1: Active Surveillance for Prostate Cancer
Oturum Başkanları: Dr. Levent Türkeri, Dr. Yaşar Bedük
13:10 – 13:25 Canadian versus U.S. Guidelines on Active Surveillance (Dr. Laurence Klotz)
Dr. Chris Evans
13:25 – 13:40 Imaging to Guide Active Surveillance (Dr. Shonit Punwani)
Dr. Yusuf Öner
13:40 – 13:55​​ Genomic Tests in Active Surveillance and the Role of Hereditary Testing (Dr. Lorelei A. Mucci)
Dr. Chris Evans
13:55 – 14:05     Tartışma

14:05 – 14:25

General Session 2: Prostate Cancer Evolution and Progression
Advances in the Understanding and Treatment of AR-Indifferent Disease (Dr. Ana Aparicio)
Dr. Chris Evans

14:25 – 15:10

Prostate Cancer: Year in Review and Keynote Lecture (Dr. James Catto)
Dr. Chris Evans
15:10 – 15:20     Tartışma
15:20 – 15:50 Kahve Molası

15:50 – 16:45

General Session 3: Challenging Cases in High-Risk, Recurrent, and Advanced Prostate Cancer
Oturum Başkanları: Dr. Feridun Şengör, Dr. Turgut Alkibay
15:50 – 16:10     Case #1: M0 vs M1 Disease
Dr. Derya Tilki
16:10 – 16:35 Case #2: Recurrent Disease
Dr. Emin Darendeliler
16:35 – 16:45     Tartışma

16:45 – 17:30

Best of Journals: Prostate Cancer
16:45 – 17:00 Dr. Derya Tilki   – (Dr. Jim C. Hu)
Urologist
17:00 – 17:15 Dr. Deniz Yalman – (Dr. Robert B. Den)
Radiation Oncologist
17:15 – 17:30 Dr. Sercan Aksoy  – (Dr. Joshua M. Lang)
Medical Oncologist

17:30 – 18:40

BLADDER CANCER
General Session 4: Optimizing Outcomes in Muscle – Invasive and Metastatic Bladder Cancer
17:30 – 17:55 Dr. Güven Aslan (1-41 Slaytlar) – (Dr. Eugene K. Lee)
Urologist
17:55 – 18:10 Dr. Yüksel Ürün (42-64 Slaytlar) (Dr. Eugene K. Lee)
Medical Oncologist
18:10 – 18:30 Dr. Fazilet Öner Dinçbaş – (Dr. Ann Henry)
Radiation Oncologist
18:30 – 18:40 Tartışma

6 Mayıs 2017,  2. Gün Cumartesi

09:00 – 09:45 Urothelial Carcinoma: Year in Review and Keynote Lecture (Dr. Matthew I. Milowsky)
Dr. Levent Türkeri

09:45 – 10:25

General Session 5: Barriers to Progress in Muscle-Invasive and Nonmuscle-Invasive Bladder Cancer
Oturum Başkanları: Dr. İbrahim Cüreklibatır, Dr. Hakan Özkardeş
09:45 – 10:00 Neoadjuvant Chemotherapy Works, but What Regimen and at What Price? (Dr. Maria De Santis)
Dr. Yüksel Ürün
10:00 – 10:15 Options for the patient who does not respond to Bacillius Calmette-Guerin when radcal cystectomy
is not an option (Dr. James M. Mckiernan)
Dr. Aydın Mungan
10:15 – 10:25 Tartışma                            
10:25 – 10:55 Kahve Arası                      

10:55 – 11:40

TESTICULAR CANCER
Oturum Başkanları: Dr. Ferruh Zorlu, Dr. Uğur Altuğ

Penile, Urethral and Testicular Cancers: Year in a Review and Keynote Lecture (Dr. Lawrence H. Einhorn)
Dr. Çağ Çal

11:40 – 12:40

Best of Journals: Renal Cancer
11:40 – 12:00 Dr. Çetin Atasoy– (Dr. Andrew D. Smith)
Radiologist
12:00 – 12:20 Dr. Cenk Yücel Bilen – (Dr. Robert G. Uzzo)
Surgical Urologist
12:20 – 12:40 Dr. Mert Başaran – (Dr. James Brugarolas)
Medical Oncologist
12:40 – 13:40 Öğle Yemeği

13:40 – 14:30

TESTICULAR CANCER
General Session 7: Novel Targets and Controversies in Advanced Testicular Cancer
Oturum Başkanları: Dr. Reşit Tokuç, Dr. Süleyman Ataus
13:40 – 14:00 Pro: Is There a Role for Treatment Intensification for Patients With Poor Prognosis Germ Cell Tumor
With Unfavorable Marker Decline? (Dr. Karim Fizazi)
Dr. Mustafa Özgüroğlu
14:00 – 14:20 Con: Is There a Role for Treatment Intensification for Patients With Poor Prognosis Germ Cell Tumor
With Unfavorable Marker Decline? (Dr. George J. Bosl)
Dr. Aziz Karaoğlu  
14:20 – 14:30 Tartışma

14:30 – 15:50

RENAL CANCER
General Session 8: Diagnosis and Treatment of Local Renal Cancer
14:30 – 14:50     The Evolving Role of Active Surveillance in Small Renal Tumors (Dr. Marc C. Smaldone)
Dr. Talha Müezzinoğlu
14:50 – 15:15     Novel Imaging Modality: Radiographic Biopsy (Dr. Mohamad E. Allaf)
Dr. Meltem Çağlar
15:15 – 15:40 Use of Ablation in Small Renal Tumors (Dr. Thomas D. Atwell)
Dr. Bülent Akdoğan
15:40 – 15:50 Tartışma
15:50 – 16:20 Kahve Molası

16:20 – 17:50

General Session 9: Opportunities and Challenges in Systemic Therapy for Advanced Renal Cancer
Oturum Başkanları: Dr. Sinan Sözen, Dr. Hakan Özveri
16:20 – 17:00 Adjuvant Therapy of Renal cell Carcinoma: Current Controversies (Dr. Jose A. Karam)
Dr. Sevil Bavbek
17:00 – 17:20 Optimal Selection of Frontile Therapies for Metastatic Renal Cell Carcinoma
(Dr. Ulka N. Vaishampayan)
Dr. Mustafa Erman
17:20 – 17:40 Evolving Treatment Using TKIs and Immunotherapy in Metastatic Renal Cell Cancer
(Dr. Eric Jonasch)
Dr. Mehmet Akif Öztürk
17:40 – 17:50 Tartışma

17:50 – 18:00

Kapanış